IPAAG Trademark
Serial Number: 79346692 • Registration: 7256695
IPAAG is a trademark filed by
Contura A/S
on March 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett,
901 New York Avenue NW
Washington
DC 20001
UNITED STATES
Trademark Details
Filing Date
March 25, 2022
Registration Date
January 2, 2024
Published for Opposition
October 17, 2023
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Dec 27, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 23, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 3, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 2, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2024 R.PR
ASSIGNED TO EXAMINER
Dec 6, 2023 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Oct 16, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 27, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 9, 2023 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 13, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jan 12, 2023 CNRT
ASSIGNED TO EXAMINER
Jan 10, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 9, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2022 REPR
